DRNA
Dicerna Pharmaceuticals Inc
Price:  
38.22 
USD
Volume:  
5,675,031.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DRNA EV/EBITDA

-166.9%
Upside

As of 2024-05-18, the EV/EBITDA ratio of Dicerna Pharmaceuticals Inc (DRNA) is -22.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRNA's latest enterprise value is 2,729.79 mil USD. DRNA's TTM EBITDA according to its financial statements is -119.65 mil USD. Dividing these 2 quantities gives us the above DRNA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.7x - 20.0x 15.4x
Forward P/E multiples 16.2x - 22.0x 19.8x
Fair Price (23.37) - (29.37) (25.57)
Upside -161.1% - -176.8% -166.9%
38.22 USD
Stock Price
(25.57) USD
Fair Price

DRNA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA